These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18544620)

  • 1. Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood.
    Recabarren SE; Sir-Petermann T; Rios R; Maliqueo M; Echiburú B; Smith R; Rojas-García P; Recabarren M; Rey RA
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3318-24. PubMed ID: 18544620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profile in sons of women with polycystic ovary syndrome.
    Recabarren SE; Smith R; Rios R; Maliqueo M; Echiburú B; Codner E; Cassorla F; Rojas P; Sir-Petermann T
    J Clin Endocrinol Metab; 2008 May; 93(5):1820-6. PubMed ID: 18230657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal function in low birth weight infants: a pilot study.
    Sir-Petermann T; Hitchsfeld C; Codner E; Maliqueo M; Iñiguez G; Echiburú B; Sánchez F; Crisosto N; Cassorla F
    J Pediatr Endocrinol Metab; 2007 Mar; 20(3):405-14. PubMed ID: 17451079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.
    Crisosto N; Codner E; Maliqueo M; Echiburú B; Sánchez F; Cassorla F; Sir-Petermann T
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2739-43. PubMed ID: 17488788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
    Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
    Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome.
    de Guevara AL; Crisosto N; Echiburú B; Preisler J; Vantman N; Bollmann J; Pérez-Bravo F; Sir-Petermann T
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):165-70. PubMed ID: 23845170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Tosi F; Negri C; Perrone F; Dorizzi R; Castello R; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2012 May; 97(5):1712-9. PubMed ID: 22419715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
    Moran LJ; Noakes M; Clifton PM; Norman RJ
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3796-802. PubMed ID: 17652213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
    Rey RA; Grinspon RP; Gottlieb S; Pasqualini T; Knoblovits P; Aszpis S; Pacenza N; Stewart Usher J; Bergadá I; Campo SM
    Andrology; 2013 Jan; 1(1):3-16. PubMed ID: 23258624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
    Das M; Gillott DJ; Saridogan E; Djahanbakhch O
    Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.